Apr. 11, 2025 — A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments.

This was a mighty challenge. The cells kept dying. Paleontologist Kyoko Hagino of Kochi University tried for twelve years until she finally cracked it with a cousin of the original organism.

The study examined health insurance claims data from July 1, 2020, through June 30, 2023. Eosinophilic esophagitis was most common among patients aged 18 to 64 years and among men. SAN DIEGO ...

A single dose of the recombinant respiratory syncytial virus (RSV) vaccine demonstrates effectiveness against infections and associated hospitalizations in veterans aged 60 years or older during ...

Apr. 9, 2025 — A new study has found that certain bacteria living in the nose may influence how likely someone is to get a COVID-19 infection. The research reveals ... Lactic Acid Bacteria Can ...

First described nearly 20 years ago, eosinophilic esophagitis (EoE) is an inflammatory disease of the esophagus characterized by eosinophilic infiltration of the esophageal epithelium. Over 50% of ...

What Is B-Cell Lymphoma? B-cell lymphoma is a cancer that forms in your white blood cells called lymphocytes. These cells are made by your lymphatic system, which plays an important role in immunity.

Eosinophilic asthma (e-asthma ... People with e-asthma have too many infection-fighting white blood cells called eosinophils in their lung tissue, blood, and mucus. These cells are ready to ...

Eosinophilic esophagitis (EoE) occurs when white blood cells called eosinophils build up in the esophagus, the tube that moves food and liquids from the throat to the stomach. This buildup of ...

Versions of another gene, RGS2, change the way some cells behave, increasing the risk ... recovery or later in life as an adult. Respiratory syncytial virus (RSV), the common cold, and influenza ...